home / stock / enscw / enscw quote
Last: | $0.03598 |
---|---|
Change Percent: | 0.0% |
Open: | $0.035 |
Close: | $0.03598 |
High: | $0.03598 |
Low: | $0.035 |
Volume: | 51,500 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.03598 | $0.035 | $0.03598 | $0.03598 | $0.035 | 51,500 | 04-18-2024 |
$0.03925 | $0.03925 | $0.03925 | $0.03925 | $0.03925 | 368 | 04-16-2024 |
$0.03896 | $0.0361 | $0.03896 | $0.03896 | $0.0361 | 11,320 | 04-15-2024 |
$0.045 | $0.042 | $0.045 | $0.045 | $0.042 | 2,104 | 04-11-2024 |
$0.038 | $0.035 | $0.038 | $0.038 | $0.035 | 83,367 | 04-10-2024 |
$0.03525 | $0.03525 | $0.03525 | $0.03525 | $0.03525 | 273 | 04-02-2024 |
$0.03 | $0.0311 | $0.03 | $0.0311 | $0.03 | 7,368 | 04-01-2024 |
$0.031 | $0.031 | $0.031 | $0.0449 | $0.031 | 82,145 | 03-29-2024 |
$0.031 | $0.031 | $0.031 | $0.0449 | $0.031 | 82,145 | 03-28-2024 |
$0.0375 | $0.045 | $0.0375 | $0.045 | $0.0375 | 1,151 | 03-27-2024 |
$0.0295 | $0.0295 | $0.0295 | $0.0295 | $0.0295 | 2,000 | 03-26-2024 |
$0.0299 | $0.0478 | $0.0299 | $0.0478 | $0.029 | 18,846 | 03-25-2024 |
$0.048 | $0.03714 | $0.048 | $0.048 | $0.03714 | 1,157 | 03-22-2024 |
$0.041895 | $0.02295 | $0.041895 | $0.041895 | $0.02295 | 738 | 03-18-2024 |
$0.04244 | $0.05 | $0.04244 | $0.05 | $0.0284 | 12,178 | 03-15-2024 |
$0.052 | $0.0388 | $0.052 | $0.052 | $0.0388 | 283 | 03-14-2024 |
$0.04625 | $0.0599 | $0.04625 | $0.0599 | $0.0284 | 21,368 | 03-13-2024 |
$0.05 | $0.015 | $0.05 | $0.05 | $0.015 | 94,854 | 03-12-2024 |
$0.0799 | $0.0799 | $0.0799 | $0.0799 | $0.0799 | 117 | 03-11-2024 |
$0.041 | $0.0223 | $0.041 | $0.041 | $0.0223 | 123,515 | 03-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ensysce Biosciences Inc Warrants (05/12/2019) Company Name:
ENSCW Stock Symbol:
OTCMKTS Market:
~ PF614-MPAR to be the Industry's First Overdose Protection Pain Product ~ SAN DIEGO, CA / ACCESSWIRE / January 25, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), (OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to improve pre...
SAN DIEGO, CA / ACCESSWIRE / January 11, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, today issued a letter to shar...
Data Expected in March 2023 SAN DIEGO, CA / ACCESSWIRE / January 4, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC, OTC:ENSCW), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, tod...